Ibalizumab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Ibalizumab, covering 2012-12-18 to 2021-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1 [Phase 3]